<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref107">
 <label>[107]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Larson</surname>
   <given-names>ME</given-names>
  </string-name>, 
  <string-name>
   <surname>Sherman</surname>
   <given-names>MA</given-names>
  </string-name>, 
  <string-name>
   <surname>Greimel</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Kuskowski</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Schneider</surname>
   <given-names>JA</given-names>
  </string-name>, 
  <string-name>
   <surname>Bennett</surname>
   <given-names>DA</given-names>
  </string-name>, 
  <string-name>
   <surname>Lesné</surname>
   <given-names>SE</given-names>
  </string-name> (
  <year>2012</year>) 
  <article-title>Soluble 
   <italic>α</italic>-synuclein is a novel modulator of Alzheimer’s disease pathophysiology
  </article-title>. 
  <source>J Neurosci</source>
  <volume>32</volume>, 
  <fpage>10253</fpage>–
  <lpage>10266</lpage>.
  <pub-id pub-id-type="pmid">22836259</pub-id>
 </mixed-citation>
</ref>
